KA
PRAH

Kerrisdale Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Kerrisdale Advisers’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-31,365
Closed -$2.6M – 80
2020
Q1 		$2.6M Sell
31,365
-80,635
-72% -$7.86M 0.5% 38
2019
Q4 		$12.4M Buy
+112,000
New +$11.5M 4.4% 9

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Kerrisdale Advisers's PRAH Position: Q2 2020 in Review

Kerrisdale Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 31,365 shares — an estimated $2.6M sold.

Kerrisdale Advisers first reported a position in PRAH in Q4 2019 and held it in 2 quarters. The position peaked at $12.4M in Q4 2019. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Kerrisdale Advisers reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Kerrisdale Advisers sold 31,365 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $2.6M.
  • Kerrisdale Advisers first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 2 quarters.
  • Kerrisdale Advisers's PRA Health Sciences, Inc. position peaked at $12.4M in Q4 2019.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Kerrisdale Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.